Neurology

From stroke to neurodegeneration — the science and its clinical impact.

Parkinson’s Disease Review Maps Symptoms, Wellness, and Persistent Gaps

A 2026 review examines Parkinson’s disease pathophysiology, symptom control, exercise, sleep, mental health, and the barriers that still block progress.

By Dr. A. Manasa, MBBS · Oct 17, 2026 · 6 min read

Neurology·MHRA

MHRA flags field safety notice for Medtronic Pipeline Vantage device

MHRA listed a field safety notice for Medtronic’s Pipeline Vantage embolization device, reinforcing manufacturer-led action on high-risk intracranial…

Oct 17, 2026

Neurology·JCI

iPSC models of neurodegeneration face aging limits, review finds

A JCI review examines how iPSC models can reveal neurodegeneration biology, and why aging remains the central barrier…

Oct 17, 2026

Neurology·Lancet ID

Delpacibart Zotadirsen Shows Exon 44 Skipping and Dystrophin Gain in DMD

Delpacibart zotadirsen increased exon 44 skipping and dystrophin expression in Duchenne muscular dystrophy mutations amenable to exon 44…

Oct 16, 2026

Neurology·Lancet Onc

UCL Live Well With Parkinson’s Toolkit Trial Evaluates Clinical and Cost Impact

A randomized trial assessed the UCL Live Well With Parkinson's toolkit for clinical and cost-effectiveness, but the abstract…

Oct 16, 2026

Neurology·Nat Rev Neuro

Updated freezing of gait definition aims to standardize Parkinson scoring

Experts issued updated clinical and technical definitions of freezing of gait to standardize scoring, improve reliability, and support…

Oct 16, 2026

Neurology·Nat Rev Neuro

Dementia risk reduction policy gains consensus in Nottingham Delphi study

A Nottingham Delphi panel reached consensus on 56 dementia prevention policy recommendations, centered on equity, public messaging and…

Oct 16, 2026

Neurology·Nat Rev Neuro

MRI Endpoints for Ataxia Trials Gain Consensus Support

A consensus statement recommends MRI biomarkers for ataxia trials, aiming to improve sensitivity, selection, and monitoring in rare…

Oct 16, 2026

Neurology·Nat Rev Neuro

Obesity linked to cognitive decline and dementia risk across the life course

A Nature Reviews Neurology review connects obesity with cognitive decline and dementia risk, detailing hypothalamic, vascular, inflammatory and…

Oct 16, 2026

Neurology·Nature

Retinal hyperspectral imaging linked to prevalent dementia in older adults

In older Japanese adults, retinal hyperspectral imaging and OCT findings were associated with prevalent dementia, with stronger odds…

Oct 16, 2026

Neurology

From stroke to neurodegeneration — the science and its clinical impact.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.